Literature DB >> 10895981

Hepatic and small bowel mucormycosis after chemotherapy in a patient with acute lymphocytic leukemia.

I W Suh1, C S Park, M S Lee, J H Lee, M S Chang, J H Woo, I C Lee, J S Ryu.   

Abstract

Mucormycosis is a rare but invasive opportunistic fungal infection with increased frequency during chemotherapy-induced neutropenia. The clinical infections due to Mucor include rhinocerebral, pulmonary, cutaneous, gastrointestinal and disseminated diseases. The first two are the most common diseases and all entities are associated with a high mortality rate. Still hepatic involvement of Mucor is rarely reported. We experienced a case of hepatic and small bowel mucormycosis in a 56-year-old woman after induction chemotherapy for B-cell acute lymphocytic leukemia. Initial symptoms were a high fever unresponsive to broad spectrum antibiotics and pain in the left lower abdominal quadrant. It was followed by septic shock, deterioration of icterus and progressively elevated transaminase. An abdominal CT demonstrated multiple hypodense lesions with distinct margins in both lobes of liver and pericolic infiltration at small bowel and ascending colon. Diagnosis was confirmed by biopsy of the liver. The histopathology of the liver showed hyphae with the right-angle branching, typical of mucormycosis. The patient was managed with amphotericin B and operative correction of the perforated part of the small bowel was performed. However, the patient expired due to progressive hepatic failure despite corrective surgery and long-term amphotericin B therapy.

Entities:  

Mesh:

Year:  2000        PMID: 10895981      PMCID: PMC3054635          DOI: 10.3346/jkms.2000.15.3.351

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  14 in total

1.  Gastrointestinal mucormycosis: an evolving disease.

Authors:  Brad Spellberg
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-02

2.  Mucormycosis presenting as recurrent gastric perforation in a patient with Crohn's disease on glucocorticoid, 6-mercaptopurine, and infliximab therapy.

Authors:  Shane M Devlin; Bing Hu; Andrew Ippoliti
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

3.  Hepatic mucormycosis mimicking hilar cholangiocarcinoma: a case report and literature review.

Authors:  Ke-Wei Li; Tian-Fu Wen; Gan-Di Li
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

Review 4.  Ileocolonic mucormycosis in adult immunocompromised patients: a surgeon's perspective.

Authors:  Oswens Siu-Hung Lo; Wai-Lun Law
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

Review 5.  Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

Authors:  Brad Spellberg; John Edwards; Ashraf Ibrahim
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

6.  Mucormycosis in immunochallenged patients.

Authors:  Jane Pak; Veronica T Tucci; Albert L Vincent; Ramon L Sandin; John N Greene
Journal:  J Emerg Trauma Shock       Date:  2008-07

7.  Gastrointestinal mucormycosis--four cases with different risk factors, involving different anatomical sites.

Authors:  Shailendra Lalwani; Mahendran Govindasamy; Manoj Gupta; Fouzia Siraj; Vibha Varma; Naimaish Mehta; Vinay Kumaran; Neelam Mohan; Prem Chopra; Anil Arora; Shyam Agarwal; Arvinder Soin; Samiran Nundy
Journal:  Indian J Gastroenterol       Date:  2012-06-29

8.  Hepatic mucormycosis in a patient of acute lymphoblastic leukemia: a case report with literature review.

Authors:  Afaq Ahmad Khan; Vinay Kumaran; Deepali Jain; Fouzia Siraj; Shyam Aggarwal
Journal:  Indian J Hematol Blood Transfus       Date:  2012-02-14       Impact factor: 0.900

9.  Outbreak of intestinal infection due to Rhizopus microsporus.

Authors:  Vincent C C Cheng; Jasper F W Chan; Antonio H Y Ngan; Kelvin K W To; S Y Leung; H W Tsoi; W C Yam; Josepha W M Tai; Samson S Y Wong; Herman Tse; Iris W S Li; Susanna K P Lau; Patrick C Y Woo; Anskar Y H Leung; Albert K W Lie; Raymond H S Liang; T L Que; P L Ho; K Y Yuen
Journal:  J Clin Microbiol       Date:  2009-07-29       Impact factor: 5.948

10.  Neutropenic Enterocolitis due to Mucormycosis in a Patient with Myelodysplastic Syndrome.

Authors:  Joon Woo Park; Joo Seop Chung; Shinwon Lee; Ho Jin Shin
Journal:  Infect Chemother       Date:  2018-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.